[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[@ExelixisInc](/creator/twitter/ExelixisInc)
"Just announced: Detailed results from the phase X pivotal trial of $EXEL novel oral kinase inhibitor in combination with an immune checkpoint inhibitor in metastatic #ColorectalCancer presented at #ESMO25 and published in @TheLancet. Learn more:"  
[X Link](https://x.com/ExelixisInc/status/1980164589519319538) [@ExelixisInc](/creator/x/ExelixisInc) 2025-10-20T06:50Z 5660 followers, XXX engagements


"See results from a subgroup analysis of the phase X pivotal trial evaluating $EXEL flagship therapy in patients with advanced #NeuroendocrineTumors (NET) at #ESMO25. Learn more:"  
[X Link](https://x.com/ExelixisInc/status/1979443962315264169) [@ExelixisInc](/creator/x/ExelixisInc) 2025-10-18T07:06Z 5657 followers, XXX engagements


"ATTN $EXEL Investors: Q3 earnings webcast coming soon. Details:"  
[X Link](https://x.com/ExelixisInc/status/1980729819727122868) [@ExelixisInc](/creator/x/ExelixisInc) 2025-10-21T20:16Z 5658 followers, XXX engagements